May 20 @ 11:30 am – 12:00 pm PDT
Innovation Theater 1
Supported By GSK
Program Description
IL-5 is a key cytokine mediator in asthma pathophysiology. Many are aware of the effects of IL-5 on eosinophils contributing to the type 2 inflammation that drives the majority of moderate to severe asthma. New evidence points to a broader and more complex role of IL-5 and its influence on other effector cells including epithelial cells, plasma cells, and fibroblasts. Join us for a review of IL-5 immunology specifically highlighting the multiple effects that contribute to airway remodeling and disease progression.
An Industry Program presentation at the ATS 2024 International Conference. This presentation is sponsored by GSK and is open to all ATS 2024 International Conference attendees.
Speakers
Presenter: Geoffrey Chupp, MD
Yale School of Medicine; Yale-New Haven Hospital
Division of Pulmonary, Critical Care and Sleep Medicine
Director, Yale Center for Asthma and Airways Disease
New Haven, Connecticut